Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Gynecology

  Free Subscription


Articles published in Int J Cancer

Retrieve available abstracts of 79 articles:
HTML format
Text format



Single Articles


    July 2017
  1. BOTTERI E, Stoer NC, Sakshaug S, Graff-Iversen S, et al
    Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
    Int J Cancer. 2017 Jul 7. doi: 10.1002/ijc.30878.
    PubMed     Text format     Abstract available


  2. BROTHERTON JM, Tabrizi SN, Phillips S, Pyman J, et al
    Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30871.
    PubMed     Text format     Abstract available


  3. KRITSCH D, Hoffmann F, Steinbach D, Jansen L, et al
    Tribbles 2 mediates cisplatin sensitivity and DNA damage response in epithelial ovarian cancer.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30860.
    PubMed     Text format     Abstract available


  4. MASSAD LS, Hessol NA, Darragh TM, Minkoff H, et al
    Cervical cancer incidence after up to 20 years of observation among women with HIV.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30866.
    PubMed     Text format     Abstract available


    June 2017
  5. BIXEL K, Saini U, Bid HK, Fowler J, et al
    Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
    Int J Cancer. 2017 Jun 24. doi: 10.1002/ijc.30847.
    PubMed     Text format     Abstract available


  6. JAREID M, Licaj I, Olsen KS, Lund E, et al
    Does an epidemiological comparison support a common cellular lineage for similar subtypes of postmenopausal uterine and ovarian carcinoma? The Norwegian Women and Cancer Study.
    Int J Cancer. 2017 Jun 8. doi: 10.1002/ijc.30826.
    PubMed     Text format     Abstract available


    May 2017
  7. MATSUO K, Shimada M, Aoki Y, Sakamoto M, et al
    Comparison of adjuvant therapy for node-positive clinical stage IB-IIB cervical cancer: Systemic chemotherapy versus pelvic irradiation.
    Int J Cancer. 2017 May 19. doi: 10.1002/ijc.30793.
    PubMed     Text format     Abstract available


  8. LAM JU, Rebolj M, Moller Ejegod D, Pedersen H, et al
    Human papillomavirus self-sampling for screening nonattenders: Opt-in pilot implementation with electronic communication platforms.
    Int J Cancer. 2017;140:2212-2219.
    PubMed     Text format     Abstract available


  9. NICOLAS-PARRAGA S, Alemany L, de Sanjose S, Bosch FX, et al
    Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.
    Int J Cancer. 2017;140:2092-2100.
    PubMed     Text format     Abstract available


    April 2017
  10. BEN KHEDHER S, Neri M, Papadopoulos A, Christiani DC, et al
    Menstrual and reproductive factors and lung cancer risk: A pooled analysis from the International Lung Cancer consortium (ILCCO).
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30750.
    PubMed     Text format     Abstract available


  11. ROHNER E, Sengayi M, Goeieman B, Michelow P, et al
    Cervical Cancer Risk and Impact of Pap-based Screening in HIV-positive Women on Antiretroviral Therapy in Johannesburg, South Africa.
    Int J Cancer. 2017 Apr 25. doi: 10.1002/ijc.30749.
    PubMed     Text format     Abstract available


  12. VERDOODT F, Kjaer Hansen M, Kjaer SK, Pottegard A, et al
    Statin use and mortality among ovarian cancer patients: A population-based cohort study.
    Int J Cancer. 2017 Apr 15. doi: 10.1002/ijc.30738.
    PubMed     Text format     Abstract available


  13. BALTZER N, Sundstrom K, Nygard JF, Dillner J, et al
    Risk Stratification in Cervical Cancer Screening by Complete Screening History- Applying Bioinformatics to a General Screening Population.
    Int J Cancer. 2017 Apr 6. doi: 10.1002/ijc.30725.
    PubMed     Text format     Abstract available


    March 2017
  14. STALBERG K, Kjolhede P, Bjurberg M, Borgfeldt C, et al
    Risk factors for lymph node metastases in women with endometrial cancer: A population-based, nation-wide register study - On behalf of the Swedish gynecological cancer group (SweGCG).
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30707.
    PubMed     Text format     Abstract available


  15. MEZEI AK, Armstrong HL, Pedersen HN, Campos NG, et al
    Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: a systematic review.
    Int J Cancer. 2017 Mar 15. doi: 10.1002/ijc.30695.
    PubMed     Text format     Abstract available


  16. HO D, Drake TK, Smith-McCune KK, Darragh TM, et al
    Feasibility of clinical detection of cervical dysplasia using angle-resolved low coherence interferometry measurements of depth-resolved nuclear morphology.
    Int J Cancer. 2017;140:1447-1456.
    PubMed     Text format     Abstract available


  17. DAS GHOSH D, Mukhopadhyay I, Bhattacharya A, Roy Chowdhury R, et al
    Impact of genetic variations and transcriptional alterations of HLA class I genes on cervical cancer pathogenesis.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30681.
    PubMed     Text format     Abstract available


  18. VAN DEN BRANDT PA, Schulpen M
    Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis.
    Int J Cancer. 2017 Mar 5. doi: 10.1002/ijc.30654.
    PubMed     Text format     Abstract available


  19. COBURN SB, Bray F, Sherman ME, Trabert B, et al
    International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.
    Int J Cancer. 2017 Mar 3. doi: 10.1002/ijc.30676.
    PubMed     Text format     Abstract available


    February 2017
  20. SHI T, Wang P, Xie C, Yin S, et al
    BRCA1 and BRCA2 mutations in ovarian cancer patients from China: Ethnic-related mutations in BRCA1 associated with an increased risk of ovarian cancer.
    Int J Cancer. 2017 Feb 8. doi: 10.1002/ijc.30633.
    PubMed     Text format     Abstract available


    January 2017
  21. HALONEN PM, Jakobsson MI, Oskari Heikinheimo MA, Riska AE, et al
    Lichen sclerosus and risk of cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30621.
    PubMed     Text format     Abstract available


  22. RODRIGUEZ AC, Avila C, Herrero R, Hildesheim A, et al
    Cervical cancer incidence after screening with HPV, cytology, and visual methods: 18-year follow-up of the Guanacaste cohort.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30614.
    PubMed     Text format     Abstract available


  23. BORCH KB, Weiderpass E, Braaten T, Jareid M, et al
    Physical activity and risk of endometrial cancer in the Norwegian Women and Cancer (NOWAC) Study.
    Int J Cancer. 2017 Jan 20. doi: 10.1002/ijc.30610.
    PubMed     Text format     Abstract available


  24. FALCONER H, Yin L, Bellocco R, Altman D, et al
    Thyroid cancer after hysterectomy on benign indications: Findings from an observational cohort study in Sweden.
    Int J Cancer. 2017 Jan 19. doi: 10.1002/ijc.30606.
    PubMed     Text format     Abstract available


  25. POLMAN NJ, Uijterwaal MH, Witte BI, Berkhof J, et al
    Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.
    Int J Cancer. 2017;140:423-430.
    PubMed     Text format     Abstract available


  26. PRAESTEGAARD C, Jensen A, Jensen SM, Nielsen TS, et al
    Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies.
    Int J Cancer. 2017 Jan 7. doi: 10.1002/ijc.30600.
    PubMed     Text format     Abstract available


  27. BAILEY HD, Rios P, Lacour B, Guerrini-Rousseau L, et al
    Factors related to pregnancy and birth and the risk of childhood brain tumours: The ESTELLE and ESCALE studies (SFCE, France).
    Int J Cancer. 2017 Jan 5. doi: 10.1002/ijc.30597.
    PubMed     Text format     Abstract available


    December 2016
  28. TANG FH, Hsieh TH, Hsu CY, Lin HY, et al
    KRAS mutation coupled with p53 loss is sufficient to induce ovarian carcinosarcomas in mice.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30591.
    PubMed     Text format     Abstract available


  29. BRUSSELAERS N, Maret-Ouda J, Konings P, El-Serag HB, et al
    Menopausal hormone therapy and the risk of esophageal and gastric cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30588.
    PubMed     Text format     Abstract available


  30. GARCIA-SANZ P, Trivino JC, Mota A, Perez Lopez M, et al
    Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
    Int J Cancer. 2016 Dec 20. doi: 10.1002/ijc.30573.
    PubMed     Text format     Abstract available


  31. AGERBAEK MO, Pereira MA, Clausen TM, Pehrson C, et al
    Burkitt lymphoma express oncofetal Chondroitin Sulfate without being a reservoir for placental malaria sequestration.
    Int J Cancer. 2016 Dec 20. doi: 10.1002/ijc.30575.
    PubMed     Text format     Abstract available


  32. CHEN W, Molijn A, Enqi W, Zhang X, et al
    The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: A hospital based nation-wide multi-center retrospective study across China.
    Int J Cancer. 2016;139:2687-2697.
    PubMed     Text format     Abstract available


  33. FORTNER RT, Husing A, Kuhn T, Konar M, et al
    Endometrial cancer risk prediction including serum-based biomarkers: Results from the EPIC cohort.
    Int J Cancer. 2016 Dec 9. doi: 10.1002/ijc.30560.
    PubMed     Text format     Abstract available


  34. CAMPOS NG, Tsu V, Jeronimo J, Mvundura M, et al
    To Expand Coverage, or Increase Frequency: Quantifying the Tradeoffs between Equity and Efficiency Facing Cervical Cancer Screening Programs in Low-Resource Settings.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30551.
    PubMed     Text format     Abstract available


  35. JONES NL, Xiu J, Chatterjee-Paer S, Buckley de Meritens A, et al
    Distinct molecular landscapes between endometrioid and non-endometrioid uterine carcinomas.
    Int J Cancer. 2016 Dec 1. doi: 10.1002/ijc.30537.
    PubMed     Text format     Abstract available


    November 2016
  36. KOCSIS A, Takacs T, Jeney C, Schaff Z, et al
    Performance of a New HPV and Biomarker Assay in Management of hrHPV Positive Women: Subanalysis of the Ongoing Multicenter TRACE Clinical Trial (n>6,000) to Evaluate POU4F3 as a Potential Biomarker of Cervical Precancer and Cancer.
    Int J Cancer. 2016 Nov 22. doi: 10.1002/ijc.30534.
    PubMed     Text format     Abstract available


  37. HABBEMA D, Weinmann S, Arbyn M, Kamineni A, et al
    Harms of Cervical Cancer Screening in the United States and the Netherlands.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30524.
    PubMed     Text format     Abstract available


  38. WAKEHAM K, Kavanagh K, Cuschieri K, Millan D, et al
    HPV status and favorable outcome in vulvar squamous cancer.
    Int J Cancer. 2016 Nov 16. doi: 10.1002/ijc.30523.
    PubMed     Text format     Abstract available


  39. TAINIO K, Jakobsson M, Louvanto K, Kalliala I, et al
    Randomised trial on treatment of vaginal intraepithelial neoplasia-Imiquimod, laser vaporisation and expectant management.
    Int J Cancer. 2016;139:2353-8.
    PubMed     Text format     Abstract available


    October 2016
  40. WU S, Wang S, Fu Y, Tang W, et al
    A novel mechanism of rs763110 polymorphism contributing to cervical cancer risk by affecting the binding affinity of CEBP/beta and OCT1 complex to chromatin.
    Int J Cancer. 2016 Oct 28. doi: 10.1002/ijc.30490.
    PubMed     Text format     Abstract available


  41. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    PubMed     Text format     Abstract available


  42. FELIX AS, Bower JK, Pfeiffer RM, Raman SV, et al
    High cardiovascular disease mortality following endometrial cancer diagnosis: Results from the Surveillance, Epidemiology, End Results Database.
    Int J Cancer. 2016 Oct 14. doi: 10.1002/ijc.30470.
    PubMed     Text format     Abstract available


  43. PERES LC, Bandera EV, Qin B, Guertin KA, et al
    Dietary Inflammatory Index and Risk of Epithelial Ovarian Cancer in African American Women.
    Int J Cancer. 2016 Oct 11. doi: 10.1002/ijc.30467.
    PubMed     Text format     Abstract available


  44. HOLT HK, Zhang L, Zhao FH, Hu SY, et al
    Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
    Int J Cancer. 2016 Oct 11. doi: 10.1002/ijc.30468.
    PubMed     Text format     Abstract available


  45. AARESTRUP J, Gamborg M, Tilling K, Ulrich LG, et al
    Childhood BMI growth trajectories and endometrial cancer risk.
    Int J Cancer. 2016 Oct 8. doi: 10.1002/ijc.30464.
    PubMed     Text format     Abstract available


  46. SCHIFFMAN M, Yu K, Zuna R, Terence Dunn S, et al
    Proof-of-principle study of a novel cervical screening and triage strategy: computer-analyzed cytology to decide which HPV-positive women are likely to have >/=CIN2.
    Int J Cancer. 2016 Oct 1. doi: 10.1002/ijc.30456.
    PubMed     Text format     Abstract available


    September 2016
  47. OGILVIE GS, Krajden M, van Niekerk D, Smith LW, et al
    HPV For Cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid based cytology for cervical cancer.
    Int J Cancer. 2016 Sep 29. doi: 10.1002/ijc.30454.
    PubMed     Text format     Abstract available


  48. HARRIS HR, Titus LJ, Cramer DW, Terry KL, et al
    Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.
    Int J Cancer. 2016 Sep 26. doi: 10.1002/ijc.30441.
    PubMed     Text format     Abstract available


  49. SIMONSSON M, Bjorner S, Markkula A, Nodin B, et al
    The prognostic impact of COX-2 expression in breast cancer depends on oral contraceptive history, preoperative NSAID use, and tumor size.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30432.
    PubMed     Text format     Abstract available


  50. KRAUS C, Hoyer J, Vasileiou G, Wunderle M, et al
    Gene panel sequencing in familial Breast/Ovarian Cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30428.
    PubMed     Text format     Abstract available


  51. KYRGIOU M, Kalliala I, Mitra A, Ng KY, et al
    Immediate referral to colposcopy vs. cytological surveillance for low-grade cervical cytological abnormalities in the absence of HPV test: A systematic review and a meta-analysis of the literature.
    Int J Cancer. 2016 Sep 7. doi: 10.1002/ijc.30419.
    PubMed     Text format     Abstract available


  52. CASTANON A, Landy R, Sasieni PD
    Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
    Int J Cancer. 2016;139:1040-5.
    PubMed     Text format     Abstract available


    August 2016
  53. VOLOSHIN T, Munster M, Blatt R, Shteingauz A, et al
    Alternating Electric Fields (TTFields) in Combination with Paclitaxel are Therapeutically Effective against Ovarian Cancer Cells in vitro and in vivo.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30406.
    PubMed     Text format     Abstract available


  54. SIMMS KT, Smith MA, Lew JB, Kitchener HC, et al
    Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
    Int J Cancer. 2016 Aug 19. doi: 10.1002/ijc.30392.
    PubMed     Text format     Abstract available


  55. ISIDEAN SD, Mayrand MH, Ramanakumar AV, Gilbert L, et al
    Human Papillomavirus Testing versus Cytology in Primary Cervical Cancer Screening: End-of-Study and Extended Follow-Up Results from the Canadian Cervical Cancer Screening Trial (CCCaST).
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30385.
    PubMed     Text format     Abstract available


  56. CAMPBELL C, Kafwafwa S, Brown H, Walker G, et al
    Use of thermo-coagulation as an alternative treatment modality in a 'screen-and-treat' programme of cervical screening in rural Malawi.
    Int J Cancer. 2016;139:908-15.
    PubMed     Text format     Abstract available


  57. SCHIFFMAN M, Hyun N, Raine-Bennett TR, Katki H, et al
    A Cohort Study of Cervical Screening Using Partial HPV Typing and Cytology Triage.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30375.
    PubMed     Text format     Abstract available


  58. MARSHALL AD, van Geldermalsen M, Otte NJ, Anderson L, et al
    LAT1 is a Putative Therapeutic Target in Endometrioid Endometrial Carcinoma.
    Int J Cancer. 2016 Aug 3. doi: 10.1002/ijc.30371.
    PubMed     Text format     Abstract available


    July 2016
  59. CADEAU C, Fournier A, Mesrine S, Clavel-Chapelon F, et al
    Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Int J Cancer. 2016 Jul 23. doi: 10.1002/ijc.30282.
    PubMed     Text format     Abstract available


  60. LEE AW, Bomkamp A, Bandera EV, Jensen A, et al
    A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer.
    Int J Cancer. 2016 Jul 15. doi: 10.1002/ijc.30274.
    PubMed     Text format     Abstract available


    June 2016
  61. DEPUYDT CE, Thys S, Beert J, Jonckheere J, et al
    Linear viral load increase of a single HPV-type in women with multiple HPV infections predicts progression to cervical cancer.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30238.
    PubMed     Text format     Abstract available


  62. ALSINA-SANCHIS E, Figueras A, Lahiguera A, Vidal A, et al
    The TGFbeta pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels.
    Int J Cancer. 2016 Jun 14. doi: 10.1002/ijc.30233.
    PubMed     Text format     Abstract available


  63. ZHAO FH, Hu SY, Zhang Q, Zhang X, et al
    Risk assessment to guide cervical screening strategies in a large Chinese population.
    Int J Cancer. 2016;138:2639-47.
    PubMed     Text format     Abstract available


    May 2016
  64. OREN R, Addadi Y, Narunsky Haziza L, Dafni H, et al
    Fibroblast recruitment as a tool for ovarian cancer detection and targeted therapy.
    Int J Cancer. 2016 May 31. doi: 10.1002/ijc.30209.
    PubMed     Text format     Abstract available


  65. KELLY Z, Moller-Levet C, McGrath S, Butler-Manuel S, et al
    The prognostic significance of specific HOX gene expression patterns in ovarian cancer.
    Int J Cancer. 2016 May 26. doi: 10.1002/ijc.30204.
    PubMed     Text format     Abstract available


  66. CARLANDER C, Wagner P, Svedhem V, Elfgren K, et al
    Impact of immunosuppression and region of birth on risk of cervical intraepithelial neoplasia among migrants living with HIV in Sweden.
    Int J Cancer. 2016 May 13. doi: 10.1002/ijc.30188.
    PubMed     Text format     Abstract available


    April 2016
  67. TANG A, Dadaglio G, Oberkampf M, Di Carlo S, et al
    B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer.
    Int J Cancer. 2016 Apr 30. doi: 10.1002/ijc.30169.
    PubMed     Text format     Abstract available


  68. RADDE K, Gottschalk A, Bussas U, Schulein S, et al
    Invitation to cervical cancer screening does increase participation in Germany: Results from the MARZY Study.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30146.
    PubMed     Text format     Abstract available


  69. CIRILLO PM, Wang ET, Cedars MI, Chen LM, et al
    Irregular menses predicts ovarian cancer: Prospective evidence from the Child Health and Development Studies.
    Int J Cancer. 2016 Apr 15. doi: 10.1002/ijc.30144.
    PubMed     Text format     Abstract available


    March 2016
  70. EBISCH RM, de Kuyper-de Ridder GM, Bosgraaf RP, Massuger LF, et al
    The clinical value of HPV genotyping in triage of women with high-risk-HPV-positive self-samples.
    Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30090.
    PubMed     Text format     Abstract available


    February 2016
  71. HERWEIJER E, Sundstrom K, Ploner A, Uhnoo I, et al
    Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
    Int J Cancer. 2016 Feb 9. doi: 10.1002/ijc.30035.
    PubMed     Text format     Abstract available


  72. PETRY KU, Cox JT, Johnson K, Quint W, et al
    Evaluating HPV negative CIN2+ in the ATHENA trial.
    Int J Cancer. 2016 Feb 6. doi: 10.1002/ijc.30032.
    PubMed     Text format     Abstract available


  73. BHATIA R, Kavanagh K, Cubie H, Serrano I, et al
    Use of HPV testing for cervical screening in vaccinated women - insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study.
    Int J Cancer. 2016 Feb 4. doi: 10.1002/ijc.30030.
    PubMed     Text format     Abstract available


    January 2016
  74. MOLIJN A, Jenkins D, Chen W, Zhang X, et al
    The complex relationship between human papillomavirus and cervical adenocarcinoma.
    Int J Cancer. 2016;138:409-16.
    PubMed     Text format     Abstract available


  75. STENSEN S, Kjaer SK, Jensen SM, Frederiksen K, et al
    Factors associated with type-specific persistence of high-risk human papillomavirus infection: A population-based study.
    Int J Cancer. 2016;138:361-8.
    PubMed     Text format     Abstract available


  76. VAN BAARS R, van der Marel J, Snijders PJ, Rodriquez-Manfredi A, et al
    CADM1 and MAL methylation status in cervical scrapes is representative of the most severe underlying lesion in women with multiple cervical biopsies.
    Int J Cancer. 2016;138:463-71.
    PubMed     Text format     Abstract available


    December 2015
  77. SKINNER SR, Wheeler CM, Romanowski B, Castellsague X, et al
    Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
    Int J Cancer. 2015 Dec 19. doi: 10.1002/ijc.29971.
    PubMed     Text format     Abstract available


    September 2015
  78. ZHANG R, Shen C, Zhao L, Wang J, et al
    Dysregulation of host cellular genes targeted by HPV integration contributes to HPV related cervical carcinogenesis.
    Int J Cancer. 2015 Sep 29. doi: 10.1002/ijc.29872.
    PubMed     Text format     Abstract available


    January 2015
  79. VERDOODT F, Jiang X, Williams M, Schnatz PF, et al
    High-risk HPV testing in the management of atypical glandular cells: a systematic review and meta-analysis.
    Int J Cancer. 2015 Jan 12. doi: 10.1002/ijc.29424.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: